Home / Latest Reports / Insulin Delivery Devices Market

Insulin Delivery Devices Market by Product and End User - Global Industry Analysis and Forecast to 2027

Published On : May 2022 Pages : 111 Category: Medical Devices Report Code : HC0623

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Industry Trend Analysis

The insulin delivery devices market is expected to be around $19 billion by 2027. The market will show tremendous growth due to increase in the number of diabetes patients owing to unhealthy lifestyle, increasing awareness about diabetic care, and technologically advanced insulin delivery devices. In addition to this, favorable reimbursement policies are set to further stimulate the market growth. However, high cost of the devices, hazards and risks associated with the drug delivery devices, and the complications associated when it comes to the delivery of insulin can hamper the market growth.

Product Outlook and Trend Analysis

Insulin pens accounted for the largest share of the insulin delivery devices market in 2017, due to rising number of diabetes patients, increasing adoption of insulin pens due to user-friendly design, and favorable reimbursement policies. Insulin pumps segment is expected to grow at the highest CAGR during the forecast period due to the increasing prevalence of Type 1 diabetes and technological advancements in insulin pumps. Growing focus of manufacturers on developing innovative and technologically advanced products is further contributing to the rising demand for these pumps.

End User Outlook and Trend Analysis

Homecare segment accounted for the largest share of the overall market in 2017 and is poised to grow at the highest CAGR during the forecast period. This is attributed to increasing diabetic population and increased adoption of insulin delivery devices by patients. Thus, ease of use and availability and accessibility of insulin delivery devices has made users to opt for insulin self-administration techniques.

Regional Outlook and Trend Analysis

North America dominated the global market in 2017, due to the increasing prevalence of diabetes owing to sedentary lifestyle in this region, high adoption of technologically advanced insulin delivery devices, and advanced healthcare infrastructure. Asia-Pacific is expected to be the fastest growing segment during the forecast period, due to presence of a large population base suffering with diabetes, rising awareness amongst individuals, growing adoption of insulin pens because of improving healthcare expenditure and disposable income of people.

Competitive Analysis

Some of the key players in the global insulin delivery devices market are Becton Dickinson and Company, Abbott, Novo Nordisk Pharmaceutical, Eli Lilly and Company, Medtronic, Sanofi, and Roche Holding AG. These companies are highly focused on the development of technologically advanced insulin delivery devices to sustain in this competitive market.

Market Opportunities

There is enormous opportunity for new and varied technologies for delivering better care across diabetes care continuum. Major players are committed for developing cluster of technologies at affordable rate that will deliver better outcomes to patients. Manufacturers are focusing on mergers and partnership for developing new devices such as drug-device combination that will enhance diabetics care management and complications associated with diabetes.

Insulin Delivery Devices Market Segmentation

By Product

  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Insulin Injectors

By End User

  • Hospitals
  • Homecare
  • Others

By Region:

  • North America
    • U.S
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Brazil
    • South Africa
    • Saudi Arabia
    • Turkey
    • United Arab Emirates
    • Others

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2022 to 2027?
  • What will be the industry market growth from 2022 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

  • Insulin Delivery Devices Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
    • Insulin Syringes
    • Insulin Pens
    • Insulin Pumps
    • Insulin Injectors
  • Insulin Delivery Devices Market, By End User, Estimates and Forecast, 2017-2027 ($Million
    • Hospitals
    • Homecare
    • Others
  • Insulin Delivery Devices Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
    • North America
  • North America Insulin Delivery Devices Market, By Country
  • North America Insulin Delivery Devices Market, By Product
  • North America Insulin Delivery Devices Market, By End User
    • U.S. Insulin Delivery Devices Market, By Product
    • U.S. Insulin Delivery Devices Market, By End User
    • Canada Insulin Delivery Devices Market, By Product
    • Canada Insulin Delivery Devices Market, By End User
    • Mexico Insulin Delivery Devices Market, By Product
    • Mexico Insulin Delivery Devices Market, By End User
    • Europe
  • Europe Insulin Delivery Devices Market, By Country
  • Europe Insulin Delivery Devices Market, By Product
  • Europe Insulin Delivery Devices Market, By End User
    • Germany Insulin Delivery Devices Market, By Product
    • Germany Insulin Delivery Devices Market, By End User
    • France Insulin Delivery Devices Market, By Product
    • France Insulin Delivery Devices Market, By End User
    • UK Insulin Delivery Devices Market, By Product
    • UK Insulin Delivery Devices Market, By End User
    • Italy Insulin Delivery Devices Market, By Product
    • Italy Insulin Delivery Devices Market, By End User
    • Spain Insulin Delivery Devices Market, By Product
    • Spain Insulin Delivery Devices Market, By End User
    • Rest of Europe Insulin Delivery Devices Market, By Product
    • Rest of Europe Insulin Delivery Devices Market, By End User
    • Asia-Pacific
      • Asia-Pacific Insulin Delivery Devices Market, By Country
      • Asia-Pacific Insulin Delivery Devices Market, By Product
      • Asia-Pacific Insulin Delivery Devices Market, By End User
        • Japan Insulin Delivery Devices Market, By Product
        • Japan Insulin Delivery Devices Market, By End User
        • China Insulin Delivery Devices Market, By Product
        • China Insulin Delivery Devices Market, By End User
        • Australia Insulin Delivery Devices Market By Product
        • Australia Insulin Delivery Devices Market, By End User
        • India Insulin Delivery Devices Market, By Product
        • India Insulin Delivery Devices Market, By End User
        • South Korea Insulin Delivery Devices Market, By Product
        • South Korea Insulin Delivery Devices Market, By End User
        • Rest of Asia-Pacific Insulin Delivery Devices Market, By Product
        • Rest of Asia-Pacific Insulin Delivery Devices Market, By End User
    • Rest of the World
      • Rest of the World Insulin Delivery Devices Market, By Country
      • Rest of the World Insulin Delivery Devices Market, By Product
      • Rest of the World Insulin Delivery Devices Market, By End User
        • Brazil Insulin Delivery Devices Market, By Product
        • Brazil Insulin Delivery Devices Market, By End User
        • South Africa Insulin Delivery Devices Market, By Product
        • South Africa Insulin Delivery Devices Market, By End User
        • Saudi Arabia Insulin Delivery Devices Market, By Product
        • Saudi Arabia Insulin Delivery Devices Market, By End User
        • Turkey Insulin Delivery Devices Market, By Product
        • Turkey Insulin Delivery Devices Market, By End User
        • United Arab Emirates Insulin Delivery Devices Market, By Product
        • United Arab Emirates Insulin Delivery Devices Market, By End User
        • Others Insulin Delivery Devices Market, By Product
        • Others Insulin Delivery Devices Market, By End User

Table of Contents

1. Introduction

1.1. Report Description

1.2. Research Methodology

1.2.1. Secondary Research

1.2.2. Primary Research

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Share Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Growing Prevalence of Diabetes

3.3.1.2. Increasing Awareness About Diabetic Care

3.3.1.3. Development of Technologically Advanced Insulin Delivery Devices

3.3.1.4. Favorable Reimbursement Policies

3.3.2. Restraints

3.3.2.1. High Cost of the Devices

3.3.2.2. Hazards and Risks Associated with the Drug Delivery Devices

3.3.2.3. Complications Associated with the Delivery of Insulin

3.3.3. Opportunities

3.3.3.1. Inhalers toRevolutionize the Insulin Delivery Devices Market

3.4. Industry Trends

3.5. Reimbursement Scenario

4. Insulin Delivery Devices Market, By Product

4.1. Introduction

4.2. Insulin Delivery Devices Market Assessment and Forecast, By Product, 2017-2027

4.3. Insulin Syringes

4.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.3.2. Insulin Pens

4.3.2.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.3.3. Insulin Pumps

4.3.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.3.4. Insulin Injectors

4.3.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

5. Insulin Delivery Devices Market, By End User

5.1. Introduction

5.2. Insulin Delivery Devices Market Assessment and Forecast, By End User, 2017-2027

5.3. Hospitals

5.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

5.4. Homecare

5.4.1.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million).

5.5. Others

5.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

6. Insulin Delivery Devices Market, By Region

6.1. Introduction

6.2. Insulin Delivery Devices Market Assessment and Forecast, By Region, 2017-2027 ($Million)

6.3. North America

6.3.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)

6.3.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.3.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.3.3.1. U.S.

6.3.3.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.3.3.1.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.3.3.2. Canada

6.3.3.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.3.3.2.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.3.3.3. Mexico

6.3.3.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.3.3.3.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.4. Europe

6.4.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)

6.4.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.4.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.4.3.1. Germany

6.4.3.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.4.3.1.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.4.3.2. France

6.4.3.2.1. Market Assessment and Forecast,By Product, 2017-2027 ($Million)

6.4.3.2.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.4.3.3. UK

6.4.3.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.4.3.3.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.4.3.4. Italy

6.4.3.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.4.3.4.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.4.3.5. Spain

6.4.3.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.4.3.5.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.4.3.6. Russia

6.4.3.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.4.3.6.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.4.3.7. Rest of Europe

6.4.3.7.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.4.3.7.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.5. Asia-Pacific

6.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)

6.5.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.5.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.5.3.1. Japan

6.5.3.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.5.3.1.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.5.3.2. China

6.5.3.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.5.3.2.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.5.3.3. Australia

6.5.3.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.5.3.3.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.5.3.4. India

6.5.3.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.5.3.4.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.5.3.5. South Korea

6.5.3.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.5.3.5.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.5.3.6. Taiwan

6.5.3.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.5.3.6.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.5.3.7. Rest of Asia-Pacific

6.5.3.7.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.5.3.7.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.6. Rest of the World

6.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)

6.6.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.6.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.6.3.1. Brazil

6.6.3.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.6.3.1.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.6.3.2. Turkey

6.6.3.2.1. Market Assessment and ForecastBy Product, 2017-2027 ($Million)

6.6.3.2.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.6.3.3. Saudi Arabia

6.6.3.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.6.3.3.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.6.3.4. South Africa

6.6.3.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.6.3.4.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.6.3.5. United Arab Emirates

6.6.3.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.6.3.5.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

6.6.3.6. Others

6.6.3.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.6.3.6.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)

7. Company Profiles

7.1. Abbott Laboratories

7.1.1. Business Overview

7.1.2. Product Portfolio

7.1.3. Key Financials

7.1.4. Strategic Developments

7.2. Novo Nordisk

7.2.1. Business Overview

7.2.2. Product Portfolio

7.2.3. Key Financials

7.2.4. Strategic Developments

7.3. Eli Lilly and Company

7.3.1. Business Overview

7.3.2. Product Portfolio

7.3.3. Key Financials

7.3.4. Strategic Developments

7.4. Medtronic Inc.

7.4.1. Business Overview

7.4.2. Product Portfolio

7.4.3. Key Financials

7.4.4. Strategic Developments

7.5. Sanofi

7.5.1. Business Overview

7.5.2. Product Portfolio

7.5.3. Key Financials

7.5.4. Strategic Developments

7.6. Becton

7.6.1. Business Overview

7.6.2. Product Portfolio

7.6.3. Key Financials

7.6.4. Strategic Developments

7.7. Dickinson and Company

7.7.1. Business Overview

7.7.2. Product Portfolio

7.7.3. Key Financials

7.7.4. Strategic Developments

7.8. F. Hoffmann-La Roche, Ltd.

7.8.1. Business Overview

7.8.2. Product Portfolio

7.8.3. Key Financials

7.8.4. Strategic Developments

7.9. B. Braun Melsungen AG

7.9.1. Business Overview

7.9.2. Product Portfolio

7.9.3. Key Financials

7.9.4. Strategic Developments

7.10. Ypsomed Holdings AG

7.10.1. Business Overview

7.10.2. Product Portfolio

7.10.3. Key Financials

7.10.4. Strategic Developments

List of Tables

Table 1.Global Insulin Delivery Devices Market, By Product ($Million), 2017-2025
Table 2.Insulin Syringes Market, By Region ($Million), 2017-2025
Table 3.Insulin Pens Market, By Region ($Million), 2017-2025
Table 4.Blood Pressure Cuffs Market, By Region ($Million), 2017-2025
Table 5.Insulin Pumps Market, By Region ($Million), 2017-2025
Table 6.Insulin Injectors Market, By Region ($Million), 2017-2025
Table 7.GlobalInsulin Delivery Devices Market, By End User ($Million), 2017-2025
Table 8.Hospitals Market, By Region ($Million), 2017-2025
Table 9.Homecare Market, By Region ($Million), 2017-2025
Table 10.Other End Users Market, By Region ($Million), 2017-2025
Table 11.Insulin Delivery Devices Market, By Region, 2017-2025 ($Million)
Table 12.North America Insulin Delivery Devices Market, By Country, 2017-2025 ($Million)
Table 13.North America Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 14.North America Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 15.U.S. Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 16.U.S. Insulin Delivery Devices Market, By End User 2017-2025 ($Million)
Table 17.Canada Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 18.Canada Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 19.Mexico Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 20.Mexico Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 21.Europe Insulin Delivery Devices Market, By Country, 2017-2025 ($Million)
Table 22.Europe Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 23.Europe Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 24.Germany Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 25.Germany Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 26.France Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 27.France Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 28.UK Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 29.UK Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 30.Italy Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 31.Italy Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 32.Spain Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 33.Spain Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 34.Rest of Europe Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 35.Rest of Europe Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 36.Asia-Pacific Insulin Delivery Devices Market, By Country, 2017-2025 ($Million)
Table 37.Asia-Pacific Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 38.Asia-Pacific Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 39.Japan Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 40.Japan Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 41.China Insulin Delivery Devices Market, By Product 2017-2025 ($Million)
Table 42.China Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 43.Australia Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 44.Australia Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 45.India Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 46.India Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 47.South Korea Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 48.South Korea Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 49.Taiwan Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 50.Taiwan Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 51.Rest of Asia-Pacific Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 52.Rest of Asia-Pacific Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 53.Rest of the World Insulin Delivery Devices Market, By Country, 2017-2025 ($Million)
Table 54.Rest of the World Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 55.Rest of the World Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 56.Brazil Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 57.Brazil Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 58.Turkey Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 59.Turkey Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 60.Saudi Arabia Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 61.Saudi Arabia Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 62.South Africa Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 63.South Africa Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 64.United Arab Emirates Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 65.United Arab Emirates Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 66.Others Insulin Delivery Devices Market, By Product, 2017-2025 ($Million)
Table 67.Others Insulin Delivery Devices Market, By End User, 2017-2025 ($Million)
Table 68.Abbott Laboratories: Key Strategic Developments, 2017-2017
Table69.Novo Nordisk: Key Strategic Developments, 2017-2017
Table 70.Eli Lilly and Company: Key Strategic Developments, 2017-2017
Table 71.Medtronic Inc.: Key Strategic Developments, 2017-2017
Table 72.Amd Global Telemedicine Inc.: Key Strategic Developments, 2017-2017
Table 73.Sanofi: Key Strategic Developments, 2017-2017
Table 74.Dickinson and Company: Key Strategic Developments, 2017-2017
Table 75.F. Hoffmann-La Roche, Ltd.: Key Strategic Developments, 2017-2017
Table 76.B.Braun Melsungen AG: Key Strategic Developments, 2017-2017
Table 77.Ypsomed Holdings AG Technology: Key Strategic Developments, 2017-2017

List of Figures

Figure 1.Global Insulin Delivery Devices Market Share, By Product, 2017 & 2025
Figure 2.Insulin Delivery Devices Market, By Region, 2017 ($Million)
Figure 3.Insulin Delivery Devices Market, By Product, 2017 ($Million)
Figure 4.Insulin Delivery Devices Market, By End User, 2017 ($Million)
Figure 5.Abbott Laboratories: Net Revenues, 2017-2017 ($Million)
Figure 6.Abbott Laboratories: Net Revenue Share, By Product, 2017
Figure 7.Abbott Laboratories: Net Revenue Share, By End User, 2017
Figure 8.Novo Nordisk: Net Revenues, 2017-2017 ($Million)
Figure 9.Novo Nordisk: Net Revenue Share, By Product, 2017
Figure 10.Novo Nordisk Revenue Share, By End User, 2017
Figure 11.Eli Lilly and Company: Net Revenues, 2017-2017 ($Million)
Figure 12.Eli Lilly and Company: Net Revenue Share, By Product, 2017
Figure 13.Eli Lilly and Company: Net Revenue Share, By End User, 2017
Figure 14.Medtronic Inc. Net Revenues, 2017-2017 ($Million)
Figure 15.Medtronic Inc.: Net Revenue Share, By Product, 2017
Figure 16.Medtronic Inc.: Net Revenue Share, By End User, 2017
Figure 17.Sanofi: Net Revenues, 2017-2017 ($Million)
Figure 18.Sanofi: Net Revenue Share, By Product, 2017
Figure 19.Sanofi: Net Revenue Share, By End User, 2017
Figure 20.Becton: Net Revenues, 2017-2017 ($Million)
Figure 21.Becton: Net Revenue Share, By Product, 2017
Figure 22.Becton: Net Revenue Share, By End User, 2017
Figure 23.Dickinson and Company: Net Revenues, 2017-2017 ($Million)
Figure 24.Dickinson and Company: Net Revenue Share, By Product, 2017
Figure 25.Dickinson and Company: Net Revenue Share, By End User, 2017
Figure 26.F. Hoffmann-La Roche, Ltd.: Net Revenues, 2017-2017 ($Million)
Figure 27.Dickinson and Company: Net Revenue Share, By Product, 2017
Figure 28.Dickinson and Company: Net Revenue Share, By End User, 2017
Figure 29.B.Braun Melsungen AG: Net Revenues, 2017-2017 ($Million)
Figure 30.B.Braun Melsungen AG: Net Revenue Share, By Product, 2017
Figure 31.B.Braun Melsungen AG: Net Revenue Share, By End User, 2017
Figure 32.Ypsomed Holdings AG Technology: Net Revenues, 2017-2017 ($Million)
Figure 33.Ypsomed Holdings AG Technology: Net Revenue Share, By Product, 2017
Figure 34.Ypsomed Holdings AG Technology: Net Revenue Share, By End User, 2017

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample

Related Reports